5hvp: Difference between revisions

Line 4:

==Overview==

The mode of binding of acetyl-pepstatin to the protease from the human, immunodeficiency virus type 1 (HIV-1) has been determined by x-ray, diffraction analysis. Crystals of an acetyl-pepstatin-HIV-1 protease, complex were obtained in space group P2(1)2(1)2 (unit cell dimensions a =, 58.39 A, b = 86.70 A, c = 46.27 A) by precipitation with sodium chloride., The structure was phased by molecular replacement methods, and a model for, the structure was refined using diffraction data to 2.0 A resolution (R =, 0.176 for 12901 reflections with I greater than sigma (I); deviation of, bond distances from ideal values = 0.018 A; 172 solvent molecules, included). The structure of the protein in the complex has been compared, with the structure of the enzyme without the ligand. A core of 44 amino, acids in each monomer, including residues in the active site and residues, at the dimer interface, remains unchanged on binding of the inhibitor, (root mean square deviation of alpha carbon positions = 0.39 A). The, remaining 55 residues in each monomer undergo substantial rearrangement, with the most dramatic changes occurring at residues 44-57 (these residues, comprise the so-called flaps of the enzyme). The flaps interact with one, another and with the inhibitor so as to largely preserve the 2-fold, symmetry of the protein. The inhibitor is bound in two approximately, symmetric orientations. In both orientations the peptidyl backbone of the, inhibitor is extended; a network of hydrogen bonds is formed between the, inhibitor and the main body of the protein as well as between the, inhibitor and the flaps. Hydrophobic side chains of residues in the body, of the protein form partial binding sites for the side chains of the, inhibitor; hydrophobic side chains of residues in the flaps complete these, binding sites.

The mode of binding of acetyl-pepstatin to the protease from the human immunodeficiency virus type 1 (HIV-1) has been determined by x-ray diffraction analysis. Crystals of an acetyl-pepstatin-HIV-1 protease complex were obtained in space group P2(1)2(1)2 (unit cell dimensions a = 58.39 A, b = 86.70 A, c = 46.27 A) by precipitation with sodium chloride. The structure was phased by molecular replacement methods, and a model for the structure was refined using diffraction data to 2.0 A resolution (R = 0.176 for 12901 reflections with I greater than sigma (I); deviation of bond distances from ideal values = 0.018 A; 172 solvent molecules included). The structure of the protein in the complex has been compared with the structure of the enzyme without the ligand. A core of 44 amino acids in each monomer, including residues in the active site and residues at the dimer interface, remains unchanged on binding of the inhibitor (root mean square deviation of alpha carbon positions = 0.39 A). The remaining 55 residues in each monomer undergo substantial rearrangement, with the most dramatic changes occurring at residues 44-57 (these residues comprise the so-called flaps of the enzyme). The flaps interact with one another and with the inhibitor so as to largely preserve the 2-fold symmetry of the protein. The inhibitor is bound in two approximately symmetric orientations. In both orientations the peptidyl backbone of the inhibitor is extended; a network of hydrogen bonds is formed between the inhibitor and the main body of the protein as well as between the inhibitor and the flaps. Hydrophobic side chains of residues in the body of the protein form partial binding sites for the side chains of the inhibitor; hydrophobic side chains of residues in the flaps complete these binding sites.

==About this Structure==

Line 13:

[[Category: Human immunodeficiency virus 1]]

[[Category: Single protein]]

[[Category: Fitzgerald, P.M.D.]]

[[Category: Fitzgerald, P M.D.]]

[[Category: Mckeever, B.M.]]

[[Category: Mckeever, B M.]]

[[Category: Springer, J.P.]]

[[Category: Springer, J P.]]

[[Category: Vanmiddlesworth, J.F.]]

[[Category: Vanmiddlesworth, J F.]]

[[Category: ACE]]

[[Category: CL]]

[[Category: hydrolase(acid proteinase)]]

''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on ~~Fri~~ Feb 15 ~~17:45~~:47 2008''

''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 19:15:29 2008''

Navigation menu

Page actions

Page actions

Personal tools

Navigation

Search

Tools

@@ Line 4: / Line 4: @@
 ==Overview==
-The mode of binding of acetyl-pepstatin to the protease from the human, immunodeficiency virus type 1 (HIV-1) has been determined by x-ray, diffraction analysis. Crystals of an acetyl-pepstatin-HIV-1 protease, complex were obtained in space group P2(1)2(1)2 (unit cell dimensions a =, 58.39 A, b = 86.70 A, c = 46.27 A) by precipitation with sodium chloride., The structure was phased by molecular replacement methods, and a model for, the structure was refined using diffraction data to 2.0 A resolution (R =, 0.176 for 12901 reflections with I greater than sigma (I); deviation of, bond distances from ideal values = 0.018 A; 172 solvent molecules, included). The structure of the protein in the complex has been compared, with the structure of the enzyme without the ligand. A core of 44 amino, acids in each monomer, including residues in the active site and residues, at the dimer interface, remains unchanged on binding of the inhibitor, (root mean square deviation of alpha carbon positions = 0.39 A). The, remaining 55 residues in each monomer undergo substantial rearrangement, with the most dramatic changes occurring at residues 44-57 (these residues, comprise the so-called flaps of the enzyme). The flaps interact with one, another and with the inhibitor so as to largely preserve the 2-fold, symmetry of the protein. The inhibitor is bound in two approximately, symmetric orientations. In both orientations the peptidyl backbone of the, inhibitor is extended; a network of hydrogen bonds is formed between the, inhibitor and the main body of the protein as well as between the, inhibitor and the flaps. Hydrophobic side chains of residues in the body, of the protein form partial binding sites for the side chains of the, inhibitor; hydrophobic side chains of residues in the flaps complete these, binding sites.
+The mode of binding of acetyl-pepstatin to the protease from the human immunodeficiency virus type 1 (HIV-1) has been determined by x-ray diffraction analysis. Crystals of an acetyl-pepstatin-HIV-1 protease complex were obtained in space group P2(1)2(1)2 (unit cell dimensions a = 58.39 A, b = 86.70 A, c = 46.27 A) by precipitation with sodium chloride. The structure was phased by molecular replacement methods, and a model for the structure was refined using diffraction data to 2.0 A resolution (R = 0.176 for 12901 reflections with I greater than sigma (I); deviation of bond distances from ideal values = 0.018 A; 172 solvent molecules included). The structure of the protein in the complex has been compared with the structure of the enzyme without the ligand. A core of 44 amino acids in each monomer, including residues in the active site and residues at the dimer interface, remains unchanged on binding of the inhibitor (root mean square deviation of alpha carbon positions = 0.39 A). The remaining 55 residues in each monomer undergo substantial rearrangement, with the most dramatic changes occurring at residues 44-57 (these residues comprise the so-called flaps of the enzyme). The flaps interact with one another and with the inhibitor so as to largely preserve the 2-fold symmetry of the protein. The inhibitor is bound in two approximately symmetric orientations. In both orientations the peptidyl backbone of the inhibitor is extended; a network of hydrogen bonds is formed between the inhibitor and the main body of the protein as well as between the inhibitor and the flaps. Hydrophobic side chains of residues in the body of the protein form partial binding sites for the side chains of the inhibitor; hydrophobic side chains of residues in the flaps complete these binding sites.
 ==About this Structure==
@@ Line 13: / Line 13: @@
 [[Category: Human immunodeficiency virus 1]]
 [[Category: Single protein]]
-[[Category: Fitzgerald, P.M.D.]]
+[[Category: Fitzgerald, P M.D.]]
-[[Category: Mckeever, B.M.]]
+[[Category: Mckeever, B M.]]
-[[Category: Springer, J.P.]]
+[[Category: Springer, J P.]]
-[[Category: Vanmiddlesworth, J.F.]]
+[[Category: Vanmiddlesworth, J F.]]
 [[Category: ACE]]
 [[Category: CL]]
 [[Category: hydrolase(acid proteinase)]]
-''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Fri Feb 15 17:45:47 2008''
+''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 19:15:29 2008''